The upcoming report from Veeva Systems (VEEV) is expected to reveal quarterly earnings of $1.58 per share, indicating an increase of 17.9% compared to the year-ago period. Analysts forecast revenues of $684.18 million, representing an increase of 11% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company announces its earnings, it ...

Veeva Systems (VEEV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended October 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Decembe ...

公司股价表现 - Veeva Systems (VEEV) 最新交易日收盘价为 $226.88，较前一交易日下跌 -0.03%，表现不及 S&P 500 指数的 0.57% 涨幅，以及道琼斯指数的 0.28% 涨幅和纳斯达克指数的 0.63% 涨幅 [1] - 过去一个月，VEEV 股价上涨 6.99%，超过计算机与科技行业 0.92% 的涨幅和 S&P 500 指数 3.15% 的涨幅 [2] 公司财务预期 - 公司将于 2024 年 12 月 5 日发布财报，预计每股收益 (EPS) 为 $1.57，同比增长 17.16%，营收预计为 $684.18 百万，同比增长 10.98% [3] - 全年来看，分析师预计每股收益为 $6.23，同比增长 28.72%，营收为 $2.71 十亿，同比增长 14.58% [4] 分析师预期与估值 - 投资者应关注分析师对 Veeva Systems 预期的近期变化，这些变化往往反映短期业务趋势的变化，正面的预期修订通常是公司业务前景良好的信号 [5] - 公司目前的 Zacks 排名为 4 (Sell)，过去一个月的 Zacks 共识 EPS 预期保持稳定 [7] - 公司当前的远期市盈率 (Forward P/E) 为 36.46，高于行业平均的 33.14，PEG 比率为 1.48，低于互联网 - 软件行业的平均 PEG 比率 2.53 [8] 行业表现 - 互联网 - 软件行业属于计算机与科技行业，目前 Zacks 行业排名为 35，位于所有 250+ 行业的顶部 14% [9] - Zacks 行业排名通过计算行业内个股的平均 Zacks 排名来评估行业实力，研究表明，排名前 50% 的行业表现优于后 50% 的行业 2 倍 [9]

Reducing content approvals from more than four weeks and automating claims are key opportunities to drive speed to marketPLEASANTON, Calif., Nov. 21, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the 2024 Veeva MedTech Commercial Benchmark survey revealing nearly 70% of medtech organizations rely on manual processes and homegrown applications to manage commercial content and claims. Without a purpose-built content management system, medtech commercial teams face go-to-market ...

PLEASANTON, Calif., Nov. 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its new cloud-based digital Hazard Analysis and Critical Control Point (HACCP) solution. Delivering HACCP management as part of the Veeva QualityOne Suite will help food and beverage manufacturers streamline food safety and quality processes, improve visibility and control over critical risks, and enable proactive quality management and compliance globally."We are honored to introduce this first-of-its-kind digital ...

In the latest market close, Veeva Systems (VEEV) reached $213.68, with a +0.15% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.39% for the day. On the other hand, the Dow registered a loss of 0.13%, and the technology-centric Nasdaq increased by 0.6%.The the stock of provider of cloud-based software services for the life sciences industry has fallen by 3.6% in the past month, lagging the Computer and Technology sector's gain of 0.59% and the S&P 500' ...

PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter, which ended October 31, 2024, after market close on December 5, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com at approximately 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website foll ...

文章核心观点 - 公司发布的最新Veeva Pulse Field Trends报告显示，同步销售和市场营销活动有助于改善生物制药公司与医疗保健专业人员（HCP）的互动效果，特别是在HCP时间有限的情况下，提供深入的科学信息可以加速治疗采用[1][2][3][4] 行业现状 - 65%的HCP互动未同步，导致治疗采用速度减慢[2][3] - HCP的时间和注意力减少，去年每位HCP的面对面会议减少了7%[2] 公司观点 - 公司认为，通过协调销售和市场营销活动，可以弥补面对面会议的减少，但目前大多数HCP互动仍未同步[2] - 公司副总裁Dan Rizzo表示，复杂的药物需要更有效的沟通方式，协调的销售和市场营销模型可以更有效地传递深入的科学信息[4] 数据支持 - 未同步的销售和市场营销活动未能优化HCP的有限时间[3] - 同步的面对面会议和数字接触点可以改善结果，例如，代表会议后10天内进行数字曝光，处方可能性增加30%，参加演讲节目后接触数字广告的HCP处方可能性增加25%，访问品牌网站后处方可能性增加60%[3] 报告介绍 - Veeva Pulse Field Trends报告分析了全球80%以上商业生物制药现场团队的超过6亿次HCP互动和活动，是该行业最大的HCP互动基准[4] - 报告通过Veeva CRM和Veeva数据产品中的实时交易数据，提供生命科学领域的互动活动视图，每季度由Veeva索引，帮助公司有效准确地基准测试性能，设定正确的可操作目标以实现持续增长和影响[4]

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Veeva Systems (VEEV) .Veeva currently has an average brokerage re ...

Veeva Systems (VEEV) closed the most recent trading day at $236.87, moving +0.8% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.1%. Meanwhile, the Dow experienced a rise of 0.69%, and the technology-dominated Nasdaq saw an increase of 0.06%.The the stock of provider of cloud-based software services for the life sciences industry has risen by 11.21% in the past month, leading the Computer and Technology sector's gain of 4.92% and the S&P 500's gain of 4. ...